Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Red fluorescence in AGA scalps is linked to different microbes.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

5-Aminolevulinic acid can help chicken sperm move better at the right amount.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Cholesterol- and phospholipid-free niosomes improve deep skin drug delivery.

Combining a 675 nm laser with isotretinoin improves acne treatment results.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

Some skin diseases and anaemia are related, and treating the skin condition can often improve the anaemia.

Liver extract treatment improved anemia and hair growth in a pig.

Long-term use of canthaxanthin may cause reversible changes in the eye, including crystal deposits and altered vision responses.

A new gene mutation causes hereditary coproporphyria with reduced enzyme activity.

PXX is an effective and affordable photocatalyst for creating new chemical bonds in organic synthesis.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Finasteride caused blisters on hands and feet.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Dihydroxyacetone in self-tanning lotion helped reduce sun-related skin issues in a woman with variegate porphyria.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

The tested hair dye ingredients do not form harmful oxidized metabolites in the liver.

Lowering homocyst(e)ine levels can reverse skin and hair lightening by restoring enzyme activity needed for pigmentation.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

1,2,3,4-tetrahydroquinoline compounds are great for stable, pure blue hair dye.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Porphyria cutanea tarda causes skin issues due to an enzyme deficiency.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.